Updates in HER2+ Early and Metastatic Breast Cancer

home / peer-exchange / updates-in-her2-early-and-metastatic-breast-cancer

A panel of experts summarizes the current HR+ breast cancer treatment landscape and discusses recent data updates in the field, including those presented at the 2022 San Antonio Breast Cancer Symposium (SABCS).